ACN Newswire Read More HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study) indie 11 1 月 3 minutes ROCKVILLE, MD and SHENZHEN, CH […]
ACN Newswire Read More 君圣泰HTD1801治疗非酒精性脂肪性肝炎(NASH)的临床IIb 期研究(CENTRICITY研究)完成首例患者给药 tallulah 11 1 月 1 minute ROCKVILLE, MD and SHENZHEN, CH […]...